Log In
Log In
Client Account Access
Equity Research Access
Fixed Income Client Portal
Macro Research Access
Merchant Banking Investor Access
Main navigation
What We Do
What We Do
Investment Banking
Public Finance
Research
Fixed Income
Alternative Asset Management
Equities
Sectors
Sectors
Chemicals
Consumer
Education
Energy & Power
Financial Services
Financial Sponsors
Government
Healthcare
Real Estate
Services & Industrials
Technology
About
About
Who We Are
Our Commitments
Our People
Insights
News
Conferences & Events
Careers
Investor Relations
Transactions
Transactions
Investment Banking
Public Finance
Contact
Search
Invalid search inquiry
Read more
about NeoleukinTherapeutics-2019-12-17
$86.2 Million
Image
Neoleukin Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about RevanceTherapeuticsInc-2019-12-04
$110.5 Million
Image
Revance Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about OptiNoseAS-2019-11-21
$53.6 Million
Image
OptiNose AS
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about Arvinas-2019-11-06
$115.0 Million
Image
Arvinas
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about ArdelyxInc-2019-12-04
$143.8 Million
Image
Ardelyx Inc
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about MeiraGTxHoldingsplc-2019-08-07
$75.2 Million
Image
MeiraGTx Holdings plc
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about SyrosPharmaceuticalsInc-2019-04-05
$65.0 Million
Image
Syros Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about KiadisPharmaBV-2019-05-31
$31.2 Million
Image
Kiadis Pharma B.V.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about SeaSpineHoldingsCorporation-2018-10-11
$57.9 Million
Image
SeaSpine Holdings Corporation
Confidentially Marketed Follow-On Offering
Active Bookrunner
Read more
about FateTherapeuticsInc-2018-09-20
$143.8 Million
Image
Fate Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Pagination
Previous page
‹‹
Page 27
Next page
››
Subscribe to Active Bookrunner